ATE286407T1 - Verfahren zur inaktivierung von pathogenen mittels breitspektrum-pulslicht - Google Patents

Verfahren zur inaktivierung von pathogenen mittels breitspektrum-pulslicht

Info

Publication number
ATE286407T1
ATE286407T1 AT00910149T AT00910149T ATE286407T1 AT E286407 T1 ATE286407 T1 AT E286407T1 AT 00910149 T AT00910149 T AT 00910149T AT 00910149 T AT00910149 T AT 00910149T AT E286407 T1 ATE286407 T1 AT E286407T1
Authority
AT
Austria
Prior art keywords
broad
composition
content
spectrum
pathogens
Prior art date
Application number
AT00910149T
Other languages
English (en)
Inventor
H William Cover
Jeffrey M Boeger
Catriona J Mcdonald
Sean Maloy
Andrew Hugh Bushnell
James Randall Cooper
Original Assignee
Purepulse Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purepulse Technologies Inc filed Critical Purepulse Technologies Inc
Application granted granted Critical
Publication of ATE286407T1 publication Critical patent/ATE286407T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08Radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05Living organisms or biological materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10Apparatus features
    • A61L2202/11Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Eye Examination Apparatus (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00910149T 1999-02-13 2000-02-11 Verfahren zur inaktivierung von pathogenen mittels breitspektrum-pulslicht ATE286407T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12003499P 1999-02-13 1999-02-13
US32901899A 1999-06-09 1999-06-09
PCT/US2000/003546 WO2000047240A1 (en) 1999-02-13 2000-02-11 Methods of inactivating pathogens using broad-spectrum pulsed light

Publications (1)

Publication Number Publication Date
ATE286407T1 true ATE286407T1 (de) 2005-01-15

Family

ID=26818000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00910149T ATE286407T1 (de) 1999-02-13 2000-02-11 Verfahren zur inaktivierung von pathogenen mittels breitspektrum-pulslicht

Country Status (13)

Country Link
EP (1) EP1152773B1 (de)
JP (1) JP2002536424A (de)
KR (1) KR100630520B1 (de)
CN (1) CN1344170A (de)
AT (1) ATE286407T1 (de)
AU (1) AU779193B2 (de)
BR (1) BR0008211A (de)
CA (1) CA2360131A1 (de)
DE (1) DE60017243T2 (de)
MX (1) MXPA01008170A (de)
NO (1) NO20013918L (de)
RU (1) RU2001125094A (de)
WO (1) WO2000047240A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7068361B2 (en) 1999-06-03 2006-06-27 Baxter International Apparatus, systems and methods for processing and treating a biological fluid with light
US6565802B1 (en) 1999-06-03 2003-05-20 Baxter International Inc. Apparatus, systems and methods for processing and treating a biological fluid with light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6843961B2 (en) 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
WO2001097868A1 (en) * 2000-06-20 2001-12-27 Purepulse Technologies, Inc. The inactivation of nucleic acids using broad-spectrum pulsed light
US20020176796A1 (en) * 2000-06-20 2002-11-28 Purepulse Technologies, Inc. Inactivation of microbes in biological fluids
AU2001296309A1 (en) * 2000-09-27 2002-04-08 Gambro, Inc Inactivation of contaminants using photosensitizers and pulsed light
US7381976B2 (en) * 2001-03-13 2008-06-03 Triton Thalassic Technologies, Inc. Monochromatic fluid treatment systems
US6613505B2 (en) 2001-04-12 2003-09-02 Bioresource International, Inc. Composition and method for destruction of infetious prion proteins
FR2947456B1 (fr) * 2009-07-06 2012-03-09 Univ Bordeaux 1 Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain
CN104023726A (zh) 2011-10-21 2014-09-03 艾伯维公司 用于治疗hcv的一种或多种daa的联合治疗(例如,与abt-072或abt-333)
CA2811203C (en) 2011-10-21 2015-05-05 Abbvie Inc. Methods for treating hcv
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
JP7129703B2 (ja) 2016-04-28 2022-09-02 エモリー ユニバーシティー アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用
US12214093B2 (en) 2017-12-20 2025-02-04 Sexton Biotechnologies, Inc. Pathogen reduced platelet compositions and related methods
CN114196719B (zh) * 2021-11-24 2023-06-13 湖北瑞邦生物科技有限公司 一种提高桑叶肽降血糖活性的工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034235A (en) * 1983-11-23 1991-07-23 Maxwell Laboratories, Inc. Methods for presevation of foodstuffs
AU3849685A (en) * 1984-02-16 1985-08-22 Molecular Biophysics Technology, Inc. Pusled light selective photcysis for sterilization of biological fluid
WO1996000091A1 (en) * 1994-06-25 1996-01-04 Opperbas Holding B.V. A method of virus inactivation in samples by uv irradiation

Also Published As

Publication number Publication date
AU779193B2 (en) 2005-01-13
EP1152773B1 (de) 2005-01-05
DE60017243T2 (de) 2005-12-08
BR0008211A (pt) 2001-11-06
NO20013918D0 (no) 2001-08-10
MXPA01008170A (es) 2002-04-24
NO20013918L (no) 2001-10-12
EP1152773A1 (de) 2001-11-14
AU3229100A (en) 2000-08-29
CN1344170A (zh) 2002-04-10
DE60017243D1 (de) 2005-02-10
JP2002536424A (ja) 2002-10-29
WO2000047240A1 (en) 2000-08-17
KR100630520B1 (ko) 2006-09-29
KR20010108199A (ko) 2001-12-07
RU2001125094A (ru) 2003-09-27
CA2360131A1 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
DE60017243D1 (de) Verfahren zur inaktivierung von pathogenen mittels breitspektrum-pulslicht
DE69027187D1 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
Yoshida et al. Peripheral blood mononuclear cells enhance the anabolic effects of platelet‐rich plasma on anterior cruciate ligament fibroblasts
DE69621161D1 (de) Verfahren und zusammensetzungen zur selektiven modifikation von nukleinsaeuren
ATE541594T1 (de) Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln
CY1118467T1 (el) Σκευασματα αντισωματων και πρωτεϊνων υψηλης συγκεντρωσης
ATE218579T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen
ATA162991A (de) Verfahren zur inaktivierung von prionen
DE69328685D1 (de) Verfahren zur inaktivierung von bakterien in blutpräparaten mit hilfe von methoxypsoralen
DE69835279D1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika
DE69325948D1 (de) Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
ATE243198T1 (de) Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen
DE69434445D1 (de) Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt
Burnouf et al. Viral safety of human platelet lysate for cell therapy and regenerative medicine: moving forward, yes, but without forgetting the past
KR20180017046A (ko) 혈소판 용해질을 멸균시키기 위한 방법
Burnouf et al. Blood‐derived biomaterials: fibrin sealant, platelet gel and platelet fibrin glue
US20090214382A1 (en) Methods of sterilizing biological mixtures using alpha-keto acids
ATE546155T1 (de) Verfahren zur stabilisierung eines kryopräzipitats von plasmatischen proteinen für eine wärmebehandlung zur viralen inaktivierung
Su et al. A virally inactivated functional growth factor preparation from human platelet concentrates
DE59711375D1 (de) Verfahren zur aktivierung von denaturiertem protein
ATE255920T1 (de) Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln
EP1499190A4 (de) Verfahren zur behandlung von lebererkrankungen und leberschäden mit wachstumshormon und foxm1b
DE602005019998D1 (de) Verfahren zur sterilisation von biologischen präparaten
ATE216399T1 (de) Verfahren zur inaktivierung von lipidumhüllten viren mit lipopeptiden und neue antivirale lipopeptide
ATE194648T1 (de) Verfahren zur inaktivierung von viren in präparationen von proteinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties